tert-Butyl 2-methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propanoate

Catalog No. :
ACEBNP485
CAS No. :
521084-36-6
Molecular Formula :
C20H31BO5
Molecular Weight :
362.27

IUPAC Name:tert-butyl 2-methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propanoate

tert-Butyl 2-methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propanoate
IUPAC Nametert-butyl 2-methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propanoate
Molecular FormulaC20H31BO5
Molecular Weight362.27
SMILESCC(C)(C)OC(=O)C(C)(C)OC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1
InChI KeyCHAWTOQQFDKYJX-UHFFFAOYSA-N
SynonymPropanoic acid, 2-methyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]-, 1,1-dimethylethyl ester
CAS No.521084-36-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACEBNP485 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACEBNP485 route product structure diagram
    ACEBNP485521084-36-6
Inquiry

2. ACEBNP485 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  4. Then
  5. ACEBNP485 route product structure diagram
    ACEBNP485521084-36-6
Inquiry

Comments (0)